Financials
- Market Capitalization 49.6 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry Case Farmaceutiche - Generali
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
0.52
Rapporto prezzo/fatturato
513.45
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4056 | OSTX OS Therapies Incorporated Common Stock | 1.63 USD | -3.55% | +4.49% | +5.84% | +41.74% | 75.19 M USD | ||
| 4166 | EXOZ eXoZymes Inc. - Common Stock | 7.21 USD | +7.13% | +0.42% | +47.44% | -25.67% | 66.92 M USD | ||
| 4279 | SCLX Scilex Holding Company - Common Stock | 5.48 USD | -0.36% | -5.84% | -16.34% | -32.60% | 46.54 M USD | ||
| 4418 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.82 USD | +6.49% | +1.23% | +5.13% | -40.15% | 34.46 M USD |